Reversibility of Dysmotility After Gastric Banding
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | May 15, 2008 | ||||
| Last Updated Date | May 15, 2008 | ||||
| Start Date ICMJE | September 2007 | ||||
| Estimated Primary Completion Date | September 2008 (final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures ICMJE |
reversibility of dysmotility after surgery [ Time Frame: 3 months ] [ Designated as safety issue: Yes ] | ||||
| Original Primary Outcome Measures ICMJE | Same as current | ||||
| Change History | No Changes Posted | ||||
| Current Secondary Outcome Measures ICMJE |
degree of dysmoztility after gastric banding [ Time Frame: not defined ] [ Designated as safety issue: Yes ] | ||||
| Original Secondary Outcome Measures ICMJE | Same as current | ||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | Reversibility of Dysmotility After Gastric Banding | ||||
| Official Title ICMJE | Reversibility of Esophageal Dysmotilities Associated With Gastric Banding After Conversion to Gastric Bypass | ||||
| Brief Summary | In the current study we plan to evaluate the effects of the conversion from gastric banding to gastric bypass on esophageal function using combined monitoring. The primary aim of the current study is to evaluate esophageal function before and 3-months after the conversion from gastric banding to gastric bypass. A second objective is to evaluate the severity of symptoms, esophageal dysmotilities, endoscopic abnormalities and bolus retention found in patients referred for conversion from gastric banding to gastric bypass. Our hypothesis is that esophageal motility disorders associated with gastric banding are reversed by conversion to gastric bypass. |
||||
| Detailed Description | 2.2.3 Research plan As model for this study we propose a longitudinal single-center study design with testing before and after the surgical intervention. Participants The study population will be limited to patients considered for gastric banding to gastric by-pass conversion. Patients will be recruited from the surgical out-patient clinic Testing during the study period Pre-OP 3 months post-OP Symptom evaluation X X Endoscopy X X Upper GI series X X Combined MII-EM X X OP - conversion of gastric band to gastric bypass After providing informed consent the volunteers will be screened for inclusion/exclusion criteria. Participants fulfilling the inclusion/exclusion criteria will undergo baseline symptom evaluation, endoscopy, an upper GI series and esophageal function testing using combined MII-EM as part of the pre-operative work-up. The same examinations (symptom evaluation, endoscopy, upper GI series and esophageal function testing) will be repeated 3 months after successful conversion from gastric band to bypass. Symptom evaluation Patients will be asked to complete a standardized esophageal symptom questionnaire. This questionnaire evaluates the frequency and severity of heartburn, chest pain, regurgitation and dysphagia which are then computed into a composite score (Eraflux score ). Endoscopy Standard sedated endoscopy will be performed by a trained gastroenterologist. The endoscopy will be performed according to the standard clinical protocol. During endoscopy the examiner will pay particular attention to the esophageal mucosa, the size of the gastric pouch above the band (baseline examination), the size of the gastric pouch above the gastro-jejunal anastomosis (post-operative examination), the presence of ulcerations at the site of gastric banding/gastric bypass. Upper GI Series Patients will undergo upper GI series using a modified timed-barium swallow (achalasia) protocol. Patients will receive 100ml liquid barium and PA images focused on the GE junction will be taken immediately after swallowing, 1 and 3 minutes later. These sequences should allow determining the position of the band relative to the GE junction and the size of the gastric pouch above the gastro-jejunal anastomosis. Esophageal function testing (EFT) On the day of esophageal motility testing an EFT probe will be placed transnasally through the esophagus into the stomach and the LES location and pressure will be determined by stationary pull-through technique. The most distal circumferential pressure sensor will be placed in the high-pressure zone (HPZ) of the LES. The other measuring sites (both pressure and impedance) will be subsequently at 5, 10, 15 and 20 cm above the HPZ of the LES. Ten swallows (5 cc each) of liquid (0.9% normal saline) and 10 swallows (5 cc each) of a standard viscous material (EFT viscous, Sandhill Scientific, Inc) will be given with each swallow 20-30 seconds apart. Analyzed parameters:
Data analysis Proportions (i.e. percentage of patients with esophageal dysmotility, patients with ulcerations at the banding/anastomosis site, etc.) will be compared using McNemar test. Continuous parameters (i.e. symptom scores, esophageal manometry and bolus transit data) recorded prior and 3-months after the conversion will be compared using paired T-tests. For statistical significance alpha will be set at 0.05. Sample size calculation Assuming that esophageal dysmotilities are present in 50% of patients prior to the conversion of banding to bypass and that conversion reduces this proportion by 50% we calculated that 40 complete datasets would be required for an 85% power to identify this change. Allowing a drop-out rate of 20% we plan to enroll 50 patients in the present study. |
||||
| Study Type ICMJE | Observational | ||||
| Study Design ICMJE | Observational Model: Case-Only Time Perspective: Prospective |
||||
| Target Follow-Up Duration | Not Provided | ||||
| Biospecimen | Not Provided | ||||
| Sampling Method | Non-Probability Sample | ||||
| Study Population | Morbidly obese patients in whom a conversion from gastric band to gastric bypass is planed |
||||
| Condition ICMJE |
|
||||
| Intervention ICMJE | Not Provided | ||||
| Study Group/Cohort (s) | 1 | ||||
| Publications * | Not Provided | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Enrolling by invitation | ||||
| Estimated Enrollment ICMJE | 50 | ||||
| Estimated Completion Date | December 2008 | ||||
| Estimated Primary Completion Date | September 2008 (final data collection date for primary outcome measure) | ||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
| Gender | Both | ||||
| Ages | 18 Years to 70 Years | ||||
| Accepts Healthy Volunteers | No | ||||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
| Location Countries ICMJE | Switzerland | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT00680030 | ||||
| Other Study ID Numbers ICMJE | EKSG 06/91 | ||||
| Has Data Monitoring Committee | Yes | ||||
| Responsible Party | PD Dr. med. Jan Borovicka, MD, Divison of Gastroenterology, Cantonal Hospital St. Gallen | ||||
| Study Sponsor ICMJE | Cantonal Hospital of St. Gallen | ||||
| Collaborators ICMJE | University of Zurich | ||||
| Investigators ICMJE |
|
||||
| Information Provided By | Cantonal Hospital of St. Gallen | ||||
| Verification Date | May 2008 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||